News

XVIVO Announces a Write-Down Related to PrimECC of SEK 17 Million Not Affecting Cashflow or EBITDA

GOTHENBURG, SWEDEN / ACCESSWIRE / December 14, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) As communicated on July 12, 2023, XVIVO…

2 years ago

Au Pair USA: Transforming Lives Through Cultural Exchange and Volunteerism

NEW YORK, NY / ACCESSWIRE / December 14, 2023 / Au Pair USA, a pioneering au pair program, continues to…

2 years ago

Vytalize Health Expands Charitable Initiative to Wipe Out Over $5.8 Million in Financial Medical Burden

The Second Contribution by the Company Eases Debt in Local Tri-State Communities Through RIP Medical DebtHOBOKEN, NJ / ACCESSWIRE /…

2 years ago

Hope On The Horizon: Tonix Pharmaceuticals (NASDAQ:TNXP) Could Be On the Cusp of Changing Fibromyalgia Treatment Options With TNX-102 SL

Topline Data from a Registration-Enabling Phase 3 Clinical Trial is Due Later This Month.CHATHAM, NJ / ACCESSWIRE / December 14,…

2 years ago

CorVive Unveils New Keto Supplement, Elevating Wellness with a Science-Backed Formula

PLANO, TX / ACCESSWIRE / December 14, 2023 / In a significant expansion of its acclaimed wellness portfolio, CorVive has…

2 years ago

Michigan Department of Health and Human Services Expands Philips Avent Pregnancy+ Program; Nearly 80% of Users Say App Has Helped Them Learn More About Locally Available Maternal Health Resources

Program reaches 12,000 Medicaid-eligible families Michigan-specific content viewed over 850,000 times in the first year Michigan expanding access to premium…

2 years ago

ModMed Boosts Its Communication Efficiency With Grammarly’s AI Writing Assistance

Grammarly’s comprehensive writing assistance with generative AI features drives 28x ROI and saves over 19 working days per year per…

2 years ago

HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights

Company Appoints Mohammad Shokoohi-Yekta to Lead Program and Industry Pioneer Lance Myers as AdvisorSANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT),…

2 years ago

Imperative Care Announces First-In-Human Study of Novel Implant Designed to Enable Single Antiplatelet Therapy After Aneurysm Treatment

● First patients treated with investigational Neurovascular Stent System by Dr. Nobuyuki Sakai at Kobe City Medical Center General Hospital,…

2 years ago

Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant)

Revolutionary, micro-invasive, injectable treatment for the full range of glaucoma disease severity iDose TR was designed to usher in a…

2 years ago